$5.7 Million EBITDA Clinical Laboratory Reagent, Equipment, and Software Distributor in Panama and Guatemala
Central American Lab Reagent Distributor with Strong Market Share
On NextCompany since August 28, 2026 (today)
Location undisclosed51 FT employees
Business overview
Three independently operated companies distribute laboratory reagents, instrumentation, and software in Guatemala and Panama. They hold 60 to 90 percent market share in immunohematology and blood typing. The customer base exceeds 90 clinical laboratories, blood banks, and hospitals. Fifty one employees handle sales, technical support, engineering, IT, and administration. Revenue and EBITDA projections remain steady for 2024. The asking price stands at $18,000,000.
Who is a good fit for this business
- Strategic buyers targeting Central American medical distribution.
- Acquirers seeking businesses with 60 to 90 percent market share in immunohematology.
- Those interested in operations with 51 retained employees across multiple functions.
Details
Frequently Asked Questions
The companies distribute laboratory reagents, instrumentation, software systems, and training. They focus on clinical laboratories and blood banks.
The companies hold an estimated 60 to 90 percent share in immunohematology and blood typing. They maintain 45 to 60 percent share in quality control usage. Over 90 accounts include government hospitals.
Fifty one employees operate across sales, technical support, applications, engineering, IT, customer service, and administration. All staff members plan to stay. Operations run independently in each country.
The asking price stands at $18,000,000. Revenue reached $12,000,000 with $5,700,000 EBITDA. American Healthcare Capital manages this listing.